Tabimorelin

• Description :

  Tabimorelin (NN703) is an orally active growth hormone (GH) secretagogue. Tabimorelin is also a potent inhibitor of CYP3A4 activity[1].

• Product Name Alternative :

  NN703

• UNSPSC :

  12352005

• Target :

  Cytochrome P450

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Endocrinology

• Assay Protocol :

  https://www.medchemexpress.com/tabimorelin.html

• Purity :

  98.11

• Solubility :

  DMSO : 25 mg/mL (ultrasonic)

• Smiles :

  CC(N)(C/C=C/C(N([C@H](CC1=CC=C2C=CC=CC2=C1)C(N([C@H](CC3=CC=CC=C3)C(NC)=O)C)=O)C)=O)C

• Molecular Formula :

  C32H40N4O3

• Molecular Weight :

  528.69

• References & Citations :

  [1]Zdravkovic M, et al. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate. Eur J Clin Pharmacol. 2003 Feb;58 (10) :683-8.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• Isoform :

  CYP3

• CAS Number :

  [193079-69-5]